Guggenheim downgrades Endava stock rating to neutral on weak results By Investing.com

Guggenheim downgraded Endava PLC to Neutral from Buy and removed its $11 price target after fiscal Q3 2026 results missed management’s outlook, citing elongated deal cycles and weaker execution. EPS came in at GBP 0.05 versus GBP 0.21 expected, a 76.2% miss, while revenue was GBP 178.5M versus GBP 183.68M consensus. The stock has fallen 19% in the past week to $3.24, near its 52-week low of $3.20, as investors await clearer visibility on revenue stabilization and margin recovery.

Analysis

This is less a one-quarter miss than a regime change in how the market should underwrite DAVA: the company is transitioning from a backlog/booking story to a financing-and-execution story. When a services name trades at ~3x forward EPS, the market is implicitly saying the earnings base is not durable; that makes any delay in large-deal conversion disproportionately damaging because fixed cost absorption and working capital efficiency both deteriorate before growth can re-accelerate.

The second-order implication is that the AI mix shift may be less of a near-term monetization engine than a defensive repositioning. Tripling AI revenue sounds impressive, but if the denominator is weakening and implementation cycles are long, AI can simply become a label applied to the same services pipeline rather than a catalyst for multiple expansion. Meanwhile, the move toward outcome-based pricing raises headline margin potential, but it also pushes more delivery and customer-concentration risk onto Endava’s balance sheet at exactly the time the company is conserving capital ahead of refinancing.

The biggest near-term risk is not another small miss; it is a sustained re-rating as estimate cuts cascade and management prioritizes liquidity over buybacks. Once buyback support fades, the stock loses an important technical bid, so downside can remain orderly until it suddenly isn’t if another quarter confirms no stabilization. Any bounce is likely to be sold unless pipeline conversion improves first, because the burden of proof has shifted from valuation to visibility.

Key Decisions for Investors

• Stay short DAVA on rallies into the next earnings window; the setup favors continued estimate cuts over the next 1-2 quarters, with asymmetric downside if management sounds cautious on pipeline conversion.
• For more defined risk, buy DAVA puts 1-2 expiries out rather than shorting outright; the catalyst path is slower, but the skew is attractive if the name breaks below its recent lows on another guidance reset.
• Avoid fading JPM on this print: the downgrade embeds a broader sell-side de-risking cycle, and further cuts from other analysts could pressure DAVA for several weeks.
• Pair trade: short DAVA vs long a profitable IT services peer with steadier conversion and stronger balance sheet; the trade works if the market continues to reward visibility and punish refinancing risk.
• If DAVA stabilizes, wait for at least one quarter of improved bookings-to-revenue conversion before considering a long; without that evidence, the stock is a value trap, not a turnaround.